Uvavanyo lweGolide olukhawulezayo lwe-Colloidal oluthengiswa nge-OEM China CE oluphawulwe yi-SARS Antigen

inkcazo emfutshane:


  • Ixesha lovavanyo:imizuzu eli-10-15
  • Ixesha Elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:Uvavanyo/ibhokisi eyi-1/25
  • Ubushushu bokugcina:2℃ -30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Inkampani yethu igxininisa kuyo yonke imigaqo-nkqubo yomgangatho ethi “umgangatho wemveliso sisiseko sokusinda kweshishini; ukwaneliseka komthengi kuya kuba yeyona nto iphambili nesiphelo senkampani; ukuphuculwa okuqhubekayo kukufuna abasebenzi ngonaphakade” kwaye injongo eqhubekayo “yokuba nodumo kuqala, umthengi kuqala” kwiWholesale OEM China CE Marked SARS Antigen Rapid Test Colloidal Gold, Asiyeki ukuphucula ubuchule bethu kunye nomgangatho ophezulu ukuze sihambisane nayo yonke indlela yokukhula kweli shishini kwaye sihlangabezane nolwaneliseko lwakho ngokufanelekileyo. Ukuba unomdla kwizisombululo zethu, nceda unxibelelane nathi ngokukhululekileyo.
    Inkampani yethu igxininisa kuyo yonke ipolisi yomgangatho ethi “umgangatho wemveliso sisiseko sokusinda kweshishini; ukwaneliseka komthengi kuya kuba yeyona nto iphambili nesiphelo senkampani; ukuphuculwa okuqhubekayo kukufuna abasebenzi ngonaphakade” kwaye injongo eqhubekayo “yokuba nodumo kuqala, umthengi kuqala”Uvavanyo lwe-SARS ye-SARS eTshayina, Uvavanyo lwe-SARS-C0V2Ngoku sicinge ngokunyanisekileyo ukunika iiarhente zophawu kwiindawo ezahlukeneyo kwaye inzuzo ephezulu yeearhente zethu yeyona nto ibalulekileyo esiyikhathaleleyo. Wamkelekile bonke abahlobo kunye nabathengi ukuba bajoyine nathi. Sikulungele ukwabelana ngenkampani eyonwabisa bonke.
    I-CEA

    cal_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu oluthe tye uluhlu lwesalathiso Uluhlu olunemigca
    Ikhithi yokuxilonga i-Carcino-embryonic antigen 25T/Ibhokisi I-Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: